Shockwave Medical (NASDAQ: SWAV)
Some price data may be temporarily unavailable.
Shockwave Medical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Shockwave Medical Company Info
Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.
News & Analysis
Why Shockwave Medical Stock Rallied as Much as 18% Higher This Week
Buyout rumors and love from Wall Street propelled the stock to double-digit gains.
3 Stocks That Could Create Lasting Generational Wealth
These three well-established growth stocks could be on the way to something much bigger.
A Bull Market Might Be Coming, but These 2 Stocks Aren't Along for the Ride Just Yet
Even as major market indexes climbed, poor financial results held a couple of companies back.
3 Healthcare Stocks to Keep an Eye On
These three lesser-known healthcare companies have strong growth potential.
Why Shockwave Medical Stock Dropped Today
The cardiovascular disease technologist delivered mixed Q2 results. Here's what investors need to know.
Why Shockwave Medical Stock Blasted More Than 10% Higher on Friday
The compay might soon be swallowed by a larger rival.
Why Shares of Shockwave Medical Jumped on Tuesday
The proposed new payment structure by the CMS would help Shockwave's business.
A Bull Market Is Coming: 1 Outstanding Growth Stock Down 36% to Buy and Hold
This up-and-coming medical technology star is set up to deliver market-beating gains for its long-term investors.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.